Manufacturer of agricultural and specialty chemicals, Porus Labs appoints Radhesh Welling as CEO

Porus Labs, a leading technology-driven manufacturer of agricultural and specialty chemicals, announced a partnership with Radhesh Welling. He will join the board and take over as the new Chief Executive Officer. Welling will build on Porus’ strengths in research & development, process innovation and deep customer relationships to drive growth in new products and chemistries that will serve both existing and new customers.

Welling has a nearly thirty-year track record of building and leading innovative, high-performance specialty chemicals companies internationally. He was earlier with Navin Fluorine, where he served as Managing Director and Group CEO since 2018. At Navin Fluorine, welling formulated and led the company’s strategic expansion and built a new organizational framework to drive significant growth over last 5 years. Previously, he worked in US with J.M.Huber Corporation.

″I am delighted to join Porus Labs, a true multi-generational business renowned for its innovation and leadership in contract manufacturing and speciality chemicals. This is a once-great opportunity to partner with Bain Capital to deliver immense value to our international customers,″ said Welling. ″Together, we will invest to further strengthen and expand the platform by creating new chemistries and helping our customers grow faster.″

″Speciality chemicals is a unique and complex industry, and we’re thrilled to partner with an experienced leader like Radhesh to help realize the company’s global growth aspirations,″ said Pawan Singh and Rishi Mandawat, Partners at Bain Capital. ″We’re aligned both in our vision for Porus Labs, and the opportunities, organically and via acquisitions, to realize those aspirations. This is a true inflection point where we can deploy our experience building global chemicals companies to form a complementary partnership with a great leader like Radhesh.″

Established in 1994 in Hyderabad, the company started with as a single manufacturing unit for all Sulpha-based drugs. Since then, Porus Labs has supported domestic API manufacturers and scaled agro-chemical capabilities as well. The company’s growth trajectory reflects its commitment to innovation and adaptability in meeting growing industry demands.